Safety and efficacy of low dose fondaparinux (1,5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment. The FONDAIR study
Academic Article
Publication Date:
2012
Iris type:
Articolo su Rivista
List of contributors:
Ageno, Walter; Riva, N; Noris, P; Di Nisio, M; La Regina, M; Arioli, D; Ria, L; Monzani, V; Cuppini, S; Lupia, E; Pierfranceschi, Mg; Dentali, Francesco
Published in: